-Outlook Aam Admi Party convenor Arvind Kejriwal today persisted with his attack on Delhi government for the second successive day, accusing it of irregularities in Delhi Jal Board and effecting 18-fold hike in the water tariff in last nine years. "Our water bill, which was Rs 74 nine years ago has swollen to Rs 1,375, which is an 18-fold growth. This is due to corruption in water distribution system under which a...
More »SEARCH RESULT
Seeking sun and wind power -Sujay Mehdudia
-The Hindu India’s investment in renewable energy was $10.4 billion in 2011 India is among the fastest growing economies in the area of renewable energy. Global players have either set up shop or are poised to enter the renewable energy area, spurred by the Jawaharlal Nehru National Solar Mission in the 11th Plan. The Government is getting ready to launch the second phase of this mission in the Twelfth Plan. According to Ernst...
More »Open and shut-Ila Patnaik
-The Indian Express FDI in retail will bring competition to non-tradable services, and make Indian firms globally competitive India removed barriers to trade in goods in the 1990s. Removing protection brought global competition and raised productivity. But introducing global competition in services is harder. In certain services that are tradable, like legal or financial services, the removal of trade barriers can introduce competition and increase productivity. But these often involve complicated and...
More »Wages upsurge driving inflation: RBI
-The Financial Express Mumbai: On Tuesday, the RBI said the path of inflation will be shaped by two sets of counteracting forces. On the downside, slower growth and excess capacity in some sectors will help moderate core inflation. “Stable, or in the best case scenario, declining commodity prices will reinforce this tendency. An appreciating rupee will also help to contain inflationary pressures by bringing down the rupee cost of imports, especially of...
More »A pharma pricing web
-The Business Standard State must get out of insulin price-setting The National Pharmaceutical Pricing Authority, or NPPA, has turned down the request of drug companies to raise insulin prices. Domestic insulin-makers Biocon and Cadila had argued that the cost of production and packaging had become higher, and multinational corporation Eli Lilly wanted the depreciation in the rupee vis-à-vis the dollar to be factored into the price. The NPPA says it has...
More »